Search

Search Results
Results 111 - 120 of 612 for Skin Cancer
  • Depo-Provera
    Drug - 8 Mar 2024
    Consumer Medicine Information (CMI) about Depo-Provera intended for persons living in Australia.
  • Mizart HCT (New)
    Drug - 23 Feb 2024
    Consumer Medicine Information (CMI) about Mizart HCT (New) (Telmisartan and Hydrochlorothiazide) intended for persons living in Australia.
  • Mvasi
    Drug - 14 Feb 2024
    Consumer Medicine Information (CMI) about Mvasi intended for persons living in Australia.
  • Bendamustine Viatris
    Drug - 14 Feb 2024
    Consumer Medicine Information (CMI) about Bendamustine Viatris (Bendamustine hydrochloride powder for injection vial) intended for persons living in Australia.
  • Olamlo HCT
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Olamlo HCT (Olmesartan medoxomil, amlodipine and hydrochlorothiazide) intended for persons living in Australia.
  • Erivedge
    Drug - 23 Nov 2022
    Consumer Medicine Information (CMI) about Erivedge intended for persons living in Australia.
  • Ribomustin
    Drug - 17 Oct 2022
    Consumer Medicine Information (CMI) about Ribomustin (Bendamustine Hydrochloride) intended for persons living in Australia.
  • Actemra
    Drug - 5 Sep 2022
    Consumer Medicine Information (CMI) about Actemra intended for persons living in Australia.
  • Adriamycin
    Drug - 13 Jul 2022
    Consumer Medicine Information (CMI) about Adriamycin (Doxorubicin hydrochloride) intended for persons living in Australia.
  • Vagifem Low
    Drug - 1 Apr 2025
    Consumer Medicine Information (CMI) about Vagifem Low (Estradiol) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback